A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study
- 1 March 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 359 (9312), 1114-1119
- https://doi.org/10.1016/s0140-6736(02)08156-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 ReceptorJournal of Biological Chemistry, 2001
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Familial hyperinsulinism and pancreatic β-cell ATP-sensitive potassium channelsKidney International, 2000
- Activation of the P2Z/P2X7Receptor in Human Lymphocytes Produces a Delayed Permeability Lesion: Involvement of Phospholipase DArchives of Biochemistry and Biophysics, 1999
- ATP, a partial agonist for the P2Z receptor of human lymphocytesBritish Journal of Pharmacology, 1997
- The Permeabilizing ATP Receptor, P2X7Journal of Biological Chemistry, 1997
- The ATP4− Receptor-Operated Channel (P2Z Class) of Human Lymphocytes Allows Ba2+ and Ethidium+ Uptake: Inhibition of Fluxes by SuraminArchives of Biochemistry and Biophysics, 1993
- Extracellular ATP as a trigger for apoptosis or programmed cell death.The Journal of cell biology, 1991
- Familial Leukaemia: A Study of 909 FamiliesScandinavian Journal of Haematology, 1975
- CHRONIC LYMPHATIC LEUKEMIA IN TWIN BROTHERS AGED FIFTY-SIXJAMA, 1929